OTC · Medical - Instruments & Supplies

Gerresheimer AG (GRRMF) Stock

$33.35 +0.00% OTC: GRRMF Healthcare

Gerresheimer AG, alongside its global subsidiaries, stands as a prominent manufacturer of packaging solutions and drug delivery devices. The company's operations are segmented into three primary divisions.

Valuation

MetricValue
Price$33.35
Market Cap$1.15B
P/E Ratio-3.12
P/B Ratio0.93
P/S Ratio0.43
EPS (TTM)$-9.27
52-Week High$56.75
52-Week Low$19.17
Dividend Yield0.15%

Financials & Margins

MetricValue
ROE-23.57%
ROA-7.13%
ROCE-6.68%
Gross Margin18.32%
Operating Margin-9.02%
Net Margin-13.80%
Debt/Equity1.48
Current Ratio0.81

Annual Financials (USD)

Metric20212022202320242025
Revenue$1.5B$1.8B$2.0B$2.0B$2.3B
Operating Profit$147.0M$169.0M$213.0M$197.0M$-209.0M
Net Profit$84.0M$96.0M$116.0M$110.0M$-320.0M
EPS$2.67$3.06$3.48$3.18$-9.27
Op Margin9.8%9.3%10.7%9.7%-9.0%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$2.9B$3.4B$3.4B$3.8B$4.5B
Total Liabilities$1.9B$2.1B$2.0B$2.3B$3.4B
Cash$114.0M$113.0M$122.0M$186.0M$176.0M
Borrowings$1.1B$1.2B$1.0B$1.3B$2.3B

Latest News

Dow Jones Futures: Micron, Sandisk, Google Lead AI Sell-Off, Netflix Dives Late; SpaceX Starship Launch Scrubbed Investor's Business Daily · Jul 17, 2026 US to Impose 25% Section 301 Tariff on Certain Brazilian Imports MT Newswires · Jul 17, 2026 Fed's Jefferson Open to Rate Hike If Inflation Persists MT Newswires · Jul 17, 2026 Royal Gold Conference Spotlights Record Q1, Acquisition-Fueled Growth Pipeline MarketBeat · Jul 17, 2026 Benchmark (BHE): Buy, Sell, or Hold Post Q1 Earnings? StockStory · Jul 17, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$212.0M$222.0M$294.0M$240.0M$210.0M
Investing Cash Flow$-401.0M$-494.0M$-635.0M$-715.0M$-970.0M
Financing Cash Flow$5.0M$0$-48.0M$-26.0M$-2.0M
Net Cash Flow$25.0M$15.0M$24.0M$62.0M$-11.0M
Free Cash Flow$8.0M$-16.0M$-34.0M$-130.0M$-99.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.01
EV / EBITDA7.75
FCF Yield-9.88%
Quick Ratio0.48
Interest Coverage-2.34
Return 1Y-45.71%
Return 3Y-74.46%
Return 5Y-66.70%

Ownership

Insiders Held10.17%
Institutions Held93.28%
Institutions Float Held103.84%
Institutional HolderSharesReport Date
Boston Common Asset Management, LLC137,7752024-12-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
BOEUFBonesupport Holding AB (publ) $20.49 +0.00% 64.38 $1.34B 0.00%
EBOSYEBOS Group Limited $26.00 +0.00% 18.22 $1.33B 5.27%
EKTAFElekta AB (publ) $5.25 +0.00% -3.80 $1.93B 4.95%
EKTAYElekta AB (publ) $4.75 +0.17% -34.36 $1.81B 5.47%
GENSFGenus plc $31.07 +0.00% 30.03 $2.06B 0.97%

About Gerresheimer AG

Gerresheimer AG, alongside its global subsidiaries, stands as a prominent manufacturer of packaging solutions and drug delivery devices. The company's operations are segmented into three primary divisions. The Plastics & Devices division supplies a comprehensive range of drug delivery systems, including inhalers, insulin pen systems, prefillable syringes, and diagnostic tools, serving the pharmaceutical, biotechnology, diagnostics, and medical technology sectors. This segment also produces various plastic containers and closures, such as PET bottles, eye droppers, nasal sprays, nebulizers, and applicators, suitable for solid, liquid, and ophthalmic preparations, in addition to bottles for nutritional supplements. Its Primary Packaging Glass division specializes in essential glass packaging for both pharmaceutical and cosmetic industries. Offerings include infusion, dropper, and syrup bottles, injection vials, ampoules, and cartridges. This division also provides miniature bottles and glass containers for liquid food, spices, and spirits, as well as sophisticated packaging for fragrances, deodorants, skincare, wellness items, and diverse beauty and pharmaceutical products. The Advanced Technologies division is dedicated to pioneering smart drug delivery systems. A notable innovation is its micro-pumps, which empower patients to self-administer medications for conditions like Parkinson's disease or heart failure, catering to pharmaceutical and biotech clients. Established in 1864, the company's corporate headquarters are located in Düsseldorf, Germany.

Gerresheimer AG is headquartered in DE.

Gerresheimer AG (GRRMF) stock trades at $33.35 with a market capitalization of $1.15B. The stock is valued at a price-to-earnings (P/E) ratio of -3.12, price-to-book of 0.93, price-to-sales of 0.43. Over the past 52 weeks the stock has ranged between $19.17 and $56.75, and currently trades 41.2% below its 52-week high. It pays a dividend yielding 0.15%.

On profitability, Gerresheimer AG generates a return on equity (ROE) of -23.57%, return on capital employed of -6.68%, an operating margin of -9.02%, a net profit margin of -13.80%.

Official website: www.gerresheimer.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides